Public pages use no advertising trackers. The secure portal uses an essential session cookie and the service providers described in our privacy policy.

Skip to main content

· Court ruling

R.C. v. Walgreen Co.

U.S. District Court for the Central District of California, 733 F. Supp. 3d 876, No. 5:23-cv-01933

Mixed rulingMotion to dismiss the second amended complaint granted in part and denied in part, with leave to amend

Primary source: Order on motion to dismiss. Checked on November 10, 2026.

Federal and California wiretap claims over a pharmacy site's alleged sharing of shoppers' health product selections with Meta survived dismissal because a viable state-law privacy claim supplied the tortious purpose.

What happened

Two shoppers, R.C. of California and T.S. of Virginia, sued Walgreen Co. over tracking code on walgreens.com. The complaint alleged that Walgreens configured the Meta Pixel, Google Tag Manager and similar tools to send Facebook, Google, Bing and Pinterest what shoppers searched for, viewed and added to their carts, along with identifiers such as IP addresses and Facebook IDs, and that it set Facebook and Google cookies disguised as first-party cookies (ECF No. 59 at 3-4).

According to the complaint, the pixel was configured to report custom events naming sensitive products, such as Plan B, HIV tests, pregnancy tests and prenatal vitamins, and its automatic advanced matching feature collected at least the first and last names shown on the checkout page (at 3-4). R.C. alleged that she placed Monistat, a yeast infection treatment, in her cart. T.S. alleged that she placed a diabetes test kit in hers and soon began receiving Facebook ads related to it (at 4-5).

The shoppers alleged that Walgreens' privacy policies promised that protected health information would not be shared for marketing without prior written permission, and that nothing on the site suggested their information would go to third parties (at 4-5). The court took judicial notice of Walgreens' online privacy policy, which said Walgreens may work with companies that place cookies, tags and web beacons on its websites and that interacting with Walgreens through the website meant consenting to the practices the policy described (at 2-3 n.2, 12).

The second amended complaint pleaded nine claims: intrusion upon seclusion, negligence, unjust enrichment, the federal Wiretap Act, the California Invasion of Privacy Act (CIPA), two claims under California's Unfair Competition Law (UCL), the Consumers Legal Remedies Act (CLRA) and the Virginia Consumer Protection Act (at 2). The order was issued by Judge Jesus G. Bernal on May 9, 2024 (at 1).

What the court held

  1. The court held that there is no legally protected privacy interest in an IP address alone, so privacy claims resting only on IP addresses fail, but that the shoppers adequately alleged that their product selections, sent with their Facebook IDs, were personally identifiable. (ECF No. 59 at 7-8)

    Thus, to the extent Plaintiffs premise any of their privacy claims on the transmission of their IP addresses alone, those claims fail.

    ECF No. 59 at 8
  2. The court rejected a bright-line rule against privacy claims based on activity on a public website and held that alleged attempts to buy specific treatments and test kits give rise to an obvious inference about the buyer's health, distinguishing Smith v. Facebook and Cousin v. Sharp Healthcare. (ECF No. 59 at 10-12)

    But an internet user is very unlikely to purchase a diabetes test kit or a yeast infection treatment for reasons unrelated to the user’s own health conditions.

    ECF No. 59 at 11
  3. The court said the question would be much closer for health-related items less indicative of a condition, such as daily vitamins, thermometers or toothpaste, and that buying beauty products or laundry detergent would be unlikely to support a privacy claim. (ECF No. 59 at 12)

  4. Walgreens' privacy policy was a browsewrap agreement that users did not have to accept, so it bound the shoppers only if they had actual or constructive knowledge of it. Taking as true their allegation that they saw nothing suggesting disclosure, the court could not find consent, and it denied dismissal of the invasion of privacy claim. (ECF No. 59 at 12-13)

    Taking that allegation as true, the Court cannot conclude that Plaintiffs consented to the disclosure they allege.

    ECF No. 59 at 13
  5. The court held that Walgreens was a party to the shoppers' communications with its website, a point the shoppers did not dispute, and applied the same party exemption analysis to the federal Wiretap Act and CIPA claims. (ECF No. 59 at 19-20)

    It is clear from the SAC that Defendant was a party to Plaintiffs’ website communications, and Plaintiffs do not dispute this contention.

    ECF No. 59 at 20
  6. The court held that the crime-tort exception can apply even where a defendant is arguably motivated by money, if the complaint adequately alleges that its conduct violated state law. Because the invasion of privacy claim was stated, the complaint pleaded tortious intent. (ECF No. 59 at 20-21)

    But even where a defendant is arguably motivated by monetary gain, the crime-tort exception may nonetheless apply if plaintiffs have adequately alleged that the defendant’s conduct violated state law, including state law privacy claims.

    ECF No. 59 at 20
  7. Intent to intercept was adequately alleged by allegations that Walgreens intentionally configured the pixels to capture both identifiers and the content of shoppers' communications. (ECF No. 59 at 21)

  8. Contents were adequately alleged: URLs that disclose search terms, search queries for treatments and data revealing health concerns are contents under CIPA and the Wiretap Act, although not every click or activity on the website will qualify. The court denied dismissal of both claims. (ECF No. 59 at 21-22)

    Such information reveals a substantive message about Plaintiffs’ health concerns.

    ECF No. 59 at 21
  9. The negligence claim was dismissed with leave to amend. The court held that a duty may arise from HIPAA under California negligence law, but found the allegations of emotional distress, lost value of the shoppers' data and future risk too conclusory or speculative to show actual loss. (ECF No. 59 at 14-17)

  10. The unjust enrichment claim survived on a disgorgement theory, because the shoppers alleged that Walgreens profited from disclosing their data without consent. (ECF No. 59 at 18-19)

  11. The UCL, CLRA and Virginia Consumer Protection Act claims were dismissed with leave to amend for failure to allege economic injury or actual loss. (ECF No. 59 at 22-23)

What it did not decide

  • Whether the privacy policy's terms, had the shoppers been on notice of them, would have disclosed the sharing they allege (ECF No. 59 at 13 n.4).
  • Whether evidence will show that the shoppers had no reasonable expectation of privacy; the court said evidence gathered in the case may ultimately show that (at 13).
  • Which particular clicks and data points are contents; the court said not every click or activity on the website will qualify (at 21-22).
  • How the invasion of privacy claim meets the requirement, which the order recites, that the crime or tort be independent of the interception itself; the order does not discuss that point separately (at 20-21).
  • Whether HIPAA applies to Walgreens' retail website or whether the shoppers' data was protected health information under HIPAA.
  • Class certification, damages and liability, which a pleading-stage order does not reach.

The tracking involved

Tools

  • Meta Pixel, including automatic advanced matching
  • Google Tag Manager
  • Facebook and Google cookies set as first-party cookies

Data

  • Product names sent as custom events, such as Plan B, HIV tests, pregnancy tests and prenatal vitamins
  • Items added to the shopping cart
  • Site search terms and descriptive URLs
  • First and last names from the checkout page
  • IP addresses and Facebook IDs

How it bears on website tracking claims

Supports: strengthens a website tracking claim on this issue. Limits: narrows or defeats a website tracking claim on this issue. Context: bears on the issue without deciding it either way.

  • Context: Party exception

    Whether the website, as a party to the visit, could consent to the tracking under 18 U.S.C. § 2511(2)(d).

    The court treated the website operator as a party to shoppers' communications with its own site, so the federal Wiretap Act and CIPA claims could proceed only through the crime-tort exception. The point was undisputed here. Under this ruling, a claim against the operator of the site had to plead a criminal or tortious purpose, not just the presence of a pixel.

    All tracker entries on this issue

  • Supports: Crime-tort exception

    Whether a communication was intercepted for the purpose of a criminal or tortious act, which removes the party exception.

    The order holds that an arguable profit motive does not end the crime-tort exception where the complaint adequately alleges a violation of state law, and it treated the surviving common-law invasion of privacy claim as that violation. It first recites the view of In re Google Inc. Gmail Litigation that the exception does not apply where the purpose is to make money rather than to injure, then explains why that did not end the claim. The predicate was a state privacy tort, not 42 U.S.C. § 1320d-6, and the order does not separately analyze whether that tort was independent of the interception.

    All tracker entries on this issue

  • Supports: Contents

    Whether what was sent, such as page addresses, searches and clicks, counts as the contents of a communication.

    The court treated search terms, descriptive URLs and data revealing which health products a shopper selected as contents of communications under both statutes. It also said that not every click or activity counts, so the result depends on what each transmission actually carried. For a retail site, product names and search terms allegedly sent to an advertising platform were enough at the pleading stage.

    All tracker entries on this issue

  • Supports: Health information

    What counts as individually identifiable health information when it is sent through tracking tools.

    Outside the patient setting, the court held that alleged attempts to buy a yeast infection treatment and a diabetes test kit relate specifically to the buyer's health and support an inference about a condition. It distinguished decisions about general health information on public pages, and it said vitamins, thermometers or toothpaste would present a much closer question. The analysis was made for the common-law invasion of privacy claim, not under HIPAA's definition of health information.

    All tracker entries on this issue

  • Supports: Consent

    Whether visitors agreed to the tracking through banners, privacy policies or terms.

    A privacy policy reached through a link at the bottom of the homepage, with no requirement to agree, was treated as a browsewrap that binds a visitor only with actual or constructive knowledge. Because the shoppers alleged they saw nothing suggesting disclosure, consent could not be found on the pleadings. The court did not decide whether the policy's statements about cookies, tags and web beacons would have been enough had notice been shown.

    All tracker entries on this issue

  • Supports: Interception

    Whether a tracking tool acquired a communication as it was sent, who did it, and whether it was intentional.

    Allegations that the operator intentionally configured pixels to capture both identifiers and the content of shoppers' communications were enough to plead intent to intercept. The court rejected the argument that the complaint failed to show Walgreens was collecting health data during the shoppers' visits.

    All tracker entries on this issue

  • Supports: State wiretap laws

    State interception statutes, such as California Penal Code § 631 and the Washington Privacy Act.

    The court decided the CIPA claim together with the federal claim, applying the same party exemption analysis to both statutes, and both survived. The order does not separately analyze any element on which CIPA section 631(a) differs from the federal statute.

    All tracker entries on this issue

  • Supports: State privacy laws

    Other state privacy statutes and claims, such as medical information and health records acts and the CCPA.

    The common-law invasion of privacy claim, which the court analyzed under California authorities, survived and served two roles: it was a claim in its own right and the tort that satisfied the crime-tort exception. The court relied on the sensitivity of the specific products and their link to Facebook IDs, not on browsing in general, and it held that an IP address alone carries no protected privacy interest.

    All tracker entries on this issue

  • Context: HIPAA

    How HIPAA, its criminal provision at 42 U.S.C. § 1320d-6 and HHS guidance bear on tracking.

    For the duty element of negligence, the order accepted that HIPAA's privacy regulations can supply a standard of care under California law, but it dismissed the negligence claim for lack of a non-speculative injury. It did not decide whether HIPAA applies to the retailer's website, and it did not rely on 42 U.S.C. § 1320d-6 for the crime-tort exception.

    All tracker entries on this issue

  • Limits: Consumer protection

    Deception and unfair practice claims, such as under the FTC Act and N.Y. General Business Law § 349.

    The UCL, CLRA and Virginia Consumer Protection Act claims failed because the shoppers did not allege economic loss; benefit-of-the-bargain and lost-data-value theories were rejected on these facts. The court distinguished a data breach case in which insurance premiums were allegedly paid in part for data security, which these shoppers could not allege for their product purchases.

    All tracker entries on this issue

Arguments it addresses

The website was a party to the communication
The court agreed that Walgreens was a party, but held that the party exemption did not defeat the Wiretap Act and CIPA claims because the complaint pleaded a tortious purpose (ECF No. 59 at 20-21).
The purpose was advertising revenue, not harming anyone
The court said a monetary motive does not by itself defeat the crime-tort exception where the complaint adequately alleges a violation of state law (at 20).
The visitor agreed to the privacy policy
A policy reached through a homepage link that did not require assent was a browsewrap, and on the shoppers' allegation that they saw nothing suggesting disclosure the court could not find consent (at 12-13).
An IP address is not private information
The court agreed as to IP addresses alone, but held that the shoppers adequately alleged that product selections sent with a Facebook ID were personally identifiable (at 7-8).
Browsing a public website reveals nothing about health
The court rejected a bright-line rule for public websites and held that alleged attempts to buy specific treatments and test kits relate to the buyer's own health, while noting that products like vitamins would be a closer case (at 10-12).
Not every click is the contents of a communication
The court agreed that not every click qualifies, but held that search terms, descriptive URLs and health product data were adequately alleged as contents (at 21-22).
No concrete economic injury
This argument succeeded against the UCL, CLRA, Virginia consumer statute and negligence claims, which were dismissed with leave to amend. It did not defeat the unjust enrichment claim, which survived on a disgorgement theory that does not require a corresponding loss, and the privacy and wiretap claims went forward (at 16-19, 22-23).

For a company that received a letter

  • This was a pleading-stage ruling that accepted the shoppers' allegations as true; it made no finding that Walgreens' site sent any particular data.
  • The court's analysis turned on what the pixel allegedly sent from specific pages, such as the specific health products placed in a shopping cart and sent with a Facebook ID, rather than on the presence of a pixel alone.
  • How the privacy policy was presented mattered: a homepage link with no step requiring agreement was treated as a browsewrap that binds visitors only with actual or constructive notice.
  • Claims under consumer statutes that require lost money or property were dismissed for lack of economic loss, while the wiretap and privacy claims went forward.

What to check on your own site

  • Check whether pixel events on product, search, cart and checkout pages carry product names, search terms or other descriptive parameters to advertising vendors.
  • Check whether Meta's automatic advanced matching is enabled for your pixel and which form fields, such as names on a checkout page, it can read.
  • Check how visitors reach your privacy policy, for example only through a link at the bottom of the page or through a step that asks them to agree.

Later history

The case remains pending. A March 18, 2025 joint report listed the claims that survived this order as intrusion upon seclusion, unjust enrichment, the federal Wiretap Act and CIPA section 631(a) (ECF No. 75). On June 11, 2026, the plaintiffs moved, without opposition, to vacate the July 28, 2026 trial date until the court rules on their motion for leave to file a third amended complaint (ECF No. 88). On June 15, 2026, the court granted that motion, vacating the trial date and continuing all pretrial deadlines, to be reset after its ruling on the motion for leave to amend (ECF No. 90). The docket lists an amended complaint filed on October 14, 2026 (ECF No. 94). On November 9, 2026, Walgreens moved to compel arbitration and to stay the case, with a hearing set for February 10, 2027 (ECF No. 98).

November 14, 2024 · Court rulingCastillo v. Costco Wholesale (W.D. Wash. 2024)Mixed rulingRuling on the pleadings, a Seattle federal court held pharmacy customers' prescription searches sent to Meta were contents and a financial motive does not defeat the crime-tort exception, but dismissed the Washington Privacy Act claim.September 7, 2023 · Court rulingDoe v. Meta Platforms (N.D. Cal. 2023)Mixed rulingPatients' Wiretap Act and CIPA claims against Meta over its pixel on health care providers' patient portals survived dismissal, with the scope of covered content, Meta's intent and the providers' consent left to evidence.July 30, 2024 · Court rulingCooper v. Mount Sinai Health System (S.D.N.Y. 2024)For plaintiffsA federal court let a Wiretap Act claim over a health system's Meta Pixel proceed, holding that alleged disclosure of identifiable patient health information for commercial ends plausibly invoked the crime-tort exception through HIPAA.February 21, 2025 · Court rulingStein v. Edward-Elmhurst Health (N.D. Ill. 2025)Mixed rulingAn Illinois federal court held that a health care provider's alleged disclosure of patient information to Facebook in violation of HIPAA satisfies the crime-tort exception, even if done for profit; the question is on appeal.September 30, 2026 · Court rulingNova v. Boston Medical Center (D. Mass. 2026)For defendantsA federal court dismissed a hospital website Wiretap Act claim, holding the allegations supported only an inference of commercial purpose and not that the data was kept in a HIPAA record set.July 29, 2026 · Court rulingDoe v. CRH Healthcare (N.D. Ga. 2026)For defendantsA Georgia federal court dismissed a Wiretap Act claim against an urgent care booking site's operator, holding its party exception applied because the negligence and fiduciary duty torts offered were not separate from the interception.

Published by Privacy Resolve from public records. It does not cover our own matters.

General information only, not legal advice, and not a substitute for the advice of an attorney. Laws, deadlines, defenses and outcomes vary by jurisdiction and facts.